Related Experiment Video
Updated: Feb 19, 2026
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
NPM1 Mutation Analysis in Acute Myeloid Leukemia: Comparison of Three Techniques - Sanger Sequencing, Pyrosequencing,
Dushyant Kumar1, Anurag Mehta2, Manoj Kumar Panigrahi1
1Gauhati University Faculty of Medicine, Department of Bioengineering and Technology, Guwahati, India.
Objective:
Nucleophosmin-1 (NPM1) mutations have prognostic importance in acute myeloid leukemia (AML) patients with intermediate-risk karyotype at diagnosis. Approximately 30% of newly diagnosed cytogenetically normal AML (CN-AML) patients harbor the NPM1 mutation in India. In this study we compared the efficiency of three molecular techniques in detecting NPM1 mutation in peripheral blood and bone marrow samples.
Materials And Methods:
In a single-center cohort we analyzed 165 CN-AML bone marrow/peripheral blood samples for NPM1 mutation analysis. About 30% of the CN-AML samples revealed NPM1 mutations. For the detection, three methods were compared: Sanger sequencing, pyrosequencing, and real-time polymerase chain reaction (PCR).
Results:
NPM1 exon 12 mutations were observed in 52 (31.51%) of all CN-AML cases. The sensitivity of Sanger sequencing, pyrosequencing, and real-time PCR was 80%, 90%, and 95%, whereas specificity was 95%, 100%, and 100%, respectively. The minimum limit of mutation detection was 20%-30% for Sanger sequencing, 1%-5% for pyrosequencing, and 0.1%-1% for real-time PCR.
Conclusion:
The sequencing method, which is the reference method, has the lowest sensitivity and is sometimes difficult to interpret. Real-time PCR is a highly sensitive method for mutation detection but is limited for specific mutation types. In our study, pyrosequencing emerged as the most suitable technique for the detection of NPM1 mutations on the basis of its easy interpretation and less time-consuming processes than Sanger sequencing.
Insights
Pyrosequencing is the most effective method for detecting Nucleophosmin-1 (NPM1) mutations in acute myeloid leukemia (AML). This technique offers better sensitivity and easier interpretation compared to Sanger sequencing and real-time PCR.
Area of Science:
- Hematology
- Molecular Diagnostics
- Oncology
Background:
- Nucleophosmin-1 (NPM1) mutations are crucial prognostic markers in acute myeloid leukemia (AML) with intermediate-risk karyotype.
- Approximately 30% of newly diagnosed cytogenetically normal AML (CN-AML) patients in India carry the NPM1 mutation.
Purpose of the Study:
- To compare the efficiency of three molecular techniques for NPM1 mutation detection.
- To evaluate Sanger sequencing, pyrosequencing, and real-time PCR in peripheral blood and bone marrow samples.
Main Methods:
- Analysis of 165 CN-AML samples from a single-center cohort.
- NPM1 mutation detection using Sanger sequencing, pyrosequencing, and real-time PCR.
Main Results:
- NPM1 exon 12 mutations were identified in 52 (31.51%) of CN-AML cases.
- Sensitivities were 80% (Sanger), 90% (pyrosequencing), and 95% (real-time PCR); specificities were 95%, 100%, and 100%, respectively.
- Detection limits varied: 20%-30% (Sanger), 1%-5% (pyrosequencing), and 0.1%-1% (real-time PCR).
Conclusions:
- Sanger sequencing, the reference method, showed lower sensitivity and interpretation challenges.
- Real-time PCR offers high sensitivity but is limited for specific mutation types.
- Pyrosequencing emerged as the most suitable technique due to its ease of interpretation and efficiency.
